{"id":"https://openalex.org/W2137115652","doi":"https://doi.org/10.1093/jnci/81.3.220","title":"Inhibition of Growth of Human Lung Adenocarcinoma Cell Lines by Anti-Transforming Growth Factor- Monoclonal Antibody","display_name":"Inhibition of Growth of Human Lung Adenocarcinoma Cell Lines by Anti-Transforming Growth Factor- Monoclonal Antibody","publication_year":1989,"publication_date":"1989-02-01","ids":{"openalex":"https://openalex.org/W2137115652","doi":"https://doi.org/10.1093/jnci/81.3.220","mag":"2137115652","pmid":"https://pubmed.ncbi.nlm.nih.gov/2783462"},"language":"en","primary_location":{"id":"doi:10.1093/jnci/81.3.220","doi":"https://doi.org/10.1093/jnci/81.3.220","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jnci/81.3.220","pdf_url":null,"source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JNCI Journal of the National Cancer Institute","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025526656","display_name":"K Imanishi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087348","display_name":"National Cancer Centre Japan","ror":"https://ror.org/0025ww868","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348"]},{"id":"https://openalex.org/I4405287541","display_name":"National Cancer Center Research Institute","ror":"https://ror.org/05fd4mq57","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405287541"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"K.-i. Imanishi","raw_affiliation_strings":["Growth Factor Division, National Cancer Center Research Institute, Tokyo, Japan","Growth Factor Division, National Cancer Center Research InstituteTsukiji 5\u20131\u20131, Chuo-ku, Tokyo 104, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Growth Factor Division, National Cancer Center Research Institute, Tokyo, Japan","institution_ids":["https://openalex.org/I4405287541"]},{"raw_affiliation_string":"Growth Factor Division, National Cancer Center Research InstituteTsukiji 5\u20131\u20131, Chuo-ku, Tokyo 104, Japan","institution_ids":["https://openalex.org/I4210087348"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006506867","display_name":"Ken D Yamaguchi","orcid":"https://orcid.org/0000-0002-7669-1405","observed_orcids":["https://orcid.org/0000-0002-7669-1405"]},"institutions":[{"id":"https://openalex.org/I4210087348","display_name":"National Cancer Centre Japan","ror":"https://ror.org/0025ww868","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348"]},{"id":"https://openalex.org/I4405287541","display_name":"National Cancer Center Research Institute","ror":"https://ror.org/05fd4mq57","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405287541"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"K. Yamaguchi","raw_affiliation_strings":["Growth Factor Division, National Cancer Center Research Institute Tsukiji 5\u20131\u20131, Chuo-ku, Tokyo 104, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Growth Factor Division, National Cancer Center Research Institute Tsukiji 5\u20131\u20131, Chuo-ku, Tokyo 104, Japan","institution_ids":["https://openalex.org/I4210087348","https://openalex.org/I4405287541"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002049972","display_name":"Masaru Kuranami","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087348","display_name":"National Cancer Centre Japan","ror":"https://ror.org/0025ww868","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348"]},{"id":"https://openalex.org/I4405287541","display_name":"National Cancer Center Research Institute","ror":"https://ror.org/05fd4mq57","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405287541"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"M. Kuranami","raw_affiliation_strings":["Growth Factor Division, National Cancer Center Research Institute Tsukiji 5\u20131\u20131, Chuo-ku, Tokyo 104, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Growth Factor Division, National Cancer Center Research Institute Tsukiji 5\u20131\u20131, Chuo-ku, Tokyo 104, Japan","institution_ids":["https://openalex.org/I4210087348","https://openalex.org/I4405287541"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086387049","display_name":"Eikai Kyo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134940","display_name":"Wakunaga (Japan)","ror":"https://ror.org/04ae5ch43","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210134940"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"E. Kyo","raw_affiliation_strings":["Institute for Biotechnology Research of Wakunaga Pharmaceutical Co., Ltd Hiroshima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Biotechnology Research of Wakunaga Pharmaceutical Co., Ltd Hiroshima, Japan","institution_ids":["https://openalex.org/I4210134940"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112160525","display_name":"Toyoharu Hozumi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134940","display_name":"Wakunaga (Japan)","ror":"https://ror.org/04ae5ch43","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210134940"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"T. Hozumi","raw_affiliation_strings":["Institute for Biotechnology Research of Wakunaga Pharmaceutical Co., Ltd Hiroshima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Biotechnology Research of Wakunaga Pharmaceutical Co., Ltd Hiroshima, Japan","institution_ids":["https://openalex.org/I4210134940"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012224957","display_name":"Kaoru Abe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087348","display_name":"National Cancer Centre Japan","ror":"https://ror.org/0025ww868","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348"]},{"id":"https://openalex.org/I4405285273","display_name":"National Cancer Center Hospital","ror":"https://ror.org/053hhpd64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405285273"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"K. Abe","raw_affiliation_strings":["Department of Medicine, National Cancer Center Hospital Tokyo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, National Cancer Center Hospital Tokyo","institution_ids":["https://openalex.org/I4210087348","https://openalex.org/I4405285273"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5436,"currency":"USD","value_usd":5436},"apc_paid":null,"fwci":6.5934,"has_fulltext":false,"cited_by_count":67,"citation_normalized_percentile":{"value":0.97014431,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"81","issue":"3","first_page":"220","last_page":"223"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.6610999703407288,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.6610999703407288,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11501","display_name":"TGF-\u03b2 signaling in diseases","score":0.2969000041484833,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.00430000014603138,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lung-adenocarcinoma","display_name":"lung adenocarcinoma","score":0.9580000042915344},{"id":"https://openalex.org/keywords/transforming-growth-factor-alpha","display_name":"transforming growth factor-alpha","score":0.9670000076293945},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.9160000085830688},{"id":"https://openalex.org/keywords/autocrine-growth-factor","display_name":"autocrine growth factor","score":0.8169999718666077},{"id":"https://openalex.org/keywords/cell-growth-inhibition","display_name":"cell growth inhibition","score":0.7540000081062317},{"id":"https://openalex.org/keywords/a549-cells","display_name":"A549 cells","score":0.9319999814033508},{"id":"https://openalex.org/keywords/pc9-cells","display_name":"PC9 cells","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tumor-cell-proliferation","display_name":"tumor cell proliferation","score":0.5419999957084656}],"concepts":[{"id":"https://openalex.org/C128240485","wikidata":"https://www.wikidata.org/wiki/Q786998","display_name":"Autocrine signalling","level":3,"score":0.9144811630249023},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.834625780582428},{"id":"https://openalex.org/C118131993","wikidata":"https://www.wikidata.org/wiki/Q423671","display_name":"Transforming growth factor","level":2,"score":0.7331753969192505},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.5979809761047363},{"id":"https://openalex.org/C2779744229","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Human lung","level":3,"score":0.5707486867904663},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.5616917014122009},{"id":"https://openalex.org/C2775960820","wikidata":"https://www.wikidata.org/wiki/Q408378","display_name":"Growth factor","level":3,"score":0.5451644062995911},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.5270098447799683},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.516216516494751},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5108789801597595},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4969325363636017},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.473734974861145},{"id":"https://openalex.org/C2779707156","wikidata":"https://www.wikidata.org/wiki/Q5611758","display_name":"Growth inhibition","level":3,"score":0.4579514265060425},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.44732025265693665},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.44692182540893555},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.43377065658569336},{"id":"https://openalex.org/C16613235","wikidata":"https://www.wikidata.org/wiki/Q285982","display_name":"Endogeny","level":2,"score":0.4330713450908661},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.420859694480896},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3645678758621216},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3124699592590332},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2790859341621399},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.25863146781921387},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21062132716178894},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.18780755996704102},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1348041296005249},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1331128478050232},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.06541454792022705},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.05968838930130005}],"mesh":[{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000918","descriptor_name":"Antibody Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004815","descriptor_name":"Epidermal Growth Factor","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D011869","descriptor_name":"Radioligand Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015291","descriptor_name":"Transforming Growth Factors","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D015291","descriptor_name":"Transforming Growth Factors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1093/jnci/81.3.220","doi":"https://doi.org/10.1093/jnci/81.3.220","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jnci/81.3.220","pdf_url":null,"source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JNCI Journal of the National Cancer Institute","raw_type":"journal-article"},{"id":"pmid:2783462","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2783462","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the National Cancer Institute","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2000739385","https://openalex.org/W2075929885","https://openalex.org/W2417981488","https://openalex.org/W1990207675","https://openalex.org/W2381084081","https://openalex.org/W2021011112","https://openalex.org/W2341045796","https://openalex.org/W7095248989","https://openalex.org/W2109509860","https://openalex.org/W2466844656"],"abstract_inverted_index":{"We":[0],"previously":[1],"reported":[2],"that":[3,46],"two":[4],"human":[5,14],"lung":[6],"adenocarcinoma":[7],"cell":[8,39],"lines":[9,40],"(A-549":[10],"and":[11,19],"PC-9)":[12],"produce":[13],"transforming":[15],"growth":[16,36,59],"factor-alpha":[17],"(hTGF-alpha)":[18],"express":[20],"its":[21],"receptors.":[22],"In":[23],"the":[24,51],"present":[25],"study":[26],"an":[27,57],"exogenously":[28],"added":[29],"monoclonal":[30],"antibody":[31],"against":[32],"recombinant":[33],"hTGF-alpha":[34,48],"inhibited":[35],"of":[37],"these":[38],"in":[41],"vitro.":[42],"This":[43],"result":[44],"indicated":[45],"endogenous":[47],"produced":[49],"by":[50],"cancer":[52],"cells":[53],"can":[54],"function":[55],"as":[56],"autocrine":[58],"factor.":[60]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}